Insider Transactions in Q4 2020 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
5,336
-39.27%
|
$218,776
$41.14 P/Share
|
|
Dec 30
2020
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
5,336
+42.76%
|
$5,336
$1.12 P/Share
|
|
Dec 18
2020
|
Mark A Goldsmith |
SELL
Bona fide gift
|
Indirect |
246,604
-49.95%
|
-
|
|
Dec 09
2020
|
Peter Svennilson Director |
BUY
Other acquisition or disposition
|
Direct |
13,068
+39.16%
|
-
|
|
Dec 09
2020
|
Peter Svennilson Director |
BUY
Other acquisition or disposition
|
Indirect |
46,914
+44.89%
|
-
|
|
Dec 09
2020
|
Peter Svennilson Director |
SELL
Other acquisition or disposition
|
Indirect |
1,046,868
-47.89%
|
-
|
|
Dec 02
2020
|
Neil Exter Director |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Dec 02
2020
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,000,000
-12.46%
|
-
|
|
Nov 16
2020
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
2,027,156
-30.68%
|
$72,977,616
$36.4 P/Share
|
|
Nov 16
2020
|
Column Group Iii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,075,133
-30.68%
|
$38,704,788
$36.4 P/Share
|
|
Nov 16
2020
|
Column Group Iii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
952,023
-30.68%
|
$34,272,828
$36.4 P/Share
|
|
Oct 15
2020
|
Elizabeth M Anderson |
SELL
Open market or private sale
|
Indirect |
4,780
-15.05%
|
$215,100
$45.0 P/Share
|
|
Oct 13
2020
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$440,000
$44.0 P/Share
|
|
Oct 13
2020
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.68 P/Share
|
|
Oct 13
2020
|
Elizabeth M Anderson |
SELL
Open market or private sale
|
Indirect |
220
-0.69%
|
$9,900
$45.0 P/Share
|
|
Oct 06
2020
|
Elizabeth M Anderson |
SELL
Open market or private sale
|
Indirect |
5,000
-13.52%
|
$200,000
$40.0 P/Share
|
|
Oct 06
2020
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$400,000
$40.0 P/Share
|
|
Oct 06
2020
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.68 P/Share
|
|
Oct 06
2020
|
Vincent A. Miller Director |
SELL
Open market or private sale
|
Direct |
6,250
-23.69%
|
$243,750
$39.0 P/Share
|
|
Oct 05
2020
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
7,196
-79.92%
|
$259,056
$36.17 P/Share
|
|
Oct 05
2020
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
7,196
+44.42%
|
$7,196
$1.12 P/Share
|
|
Oct 02
2020
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
804
-30.78%
|
$28,944
$36.02 P/Share
|
|
Oct 02
2020
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
804
+23.54%
|
$804
$1.12 P/Share
|
|
Oct 02
2020
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
12,495
-18.99%
|
$437,325
$35.4 P/Share
|
|
Oct 01
2020
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
2,000
-52.52%
|
$68,000
$34.76 P/Share
|
|
Oct 01
2020
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+34.44%
|
$2,000
$1.12 P/Share
|
|
Oct 01
2020
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
57,505
-46.64%
|
$2,012,675
$35.01 P/Share
|